191 related articles for article (PubMed ID: 23284922)
1. Global effect of inauhzin on human p53-responsive transcriptome.
Liao JM; Zeng SX; Zhou X; Lu H
PLoS One; 2012; 7(12):e52172. PubMed ID: 23284922
[TBL] [Abstract][Full Text] [Related]
2. Inauhzin(c) inactivates c-Myc independently of p53.
Jung JH; Liao JM; Zhang Q; Zeng S; Nguyen D; Hao Q; Zhou X; Cao B; Kim SH; Lu H
Cancer Biol Ther; 2015; 16(3):412-9. PubMed ID: 25692307
[TBL] [Abstract][Full Text] [Related]
3. A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53.
Zhang Q; Zeng SX; Zhang Y; Zhang Y; Ding D; Ye Q; Meroueh SO; Lu H
EMBO Mol Med; 2012 Apr; 4(4):298-312. PubMed ID: 22331558
[TBL] [Abstract][Full Text] [Related]
4. Structure and activity analysis of Inauhzin analogs as novel antitumor compounds that induce p53 and inhibit cell growth.
Zhang Q; Ding D; Zeng SX; Ye QZ; Lu H
PLoS One; 2012; 7(10):e46294. PubMed ID: 23115626
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle encapsulation of non-genotoxic p53 activator Inauhzin-C for improved therapeutic efficacy.
Bhattarai N; Wang J; Nguyen D; Yang X; Helmers L; Paruch J; Li L; Zhang Y; Meng K; Wang A; Jayawickramarajah J; Wang B; Zeng S; Lu H
Theranostics; 2021; 11(14):7005-7017. PubMed ID: 34093867
[TBL] [Abstract][Full Text] [Related]
6. TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene.
Liao JM; Cao B; Deng J; Zhou X; Strong M; Zeng S; Xiong J; Flemington E; Lu H
Sci Rep; 2016 Mar; 6():23542. PubMed ID: 27005522
[TBL] [Abstract][Full Text] [Related]
7. The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress.
Zhang Q; Zhou X; Wu R; Mosley A; Zeng SX; Xing Z; Lu H
Elife; 2014 Oct; 3():. PubMed ID: 25347121
[TBL] [Abstract][Full Text] [Related]
8. Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents.
Zhang Y; Zhang Q; Zeng SX; Hao Q; Lu H
Neoplasia; 2013 May; 15(5):523-34. PubMed ID: 23633924
[TBL] [Abstract][Full Text] [Related]
9. Calcium-oxidative stress signaling axis and casein kinase 1α mediate eryptosis and hemolysis elicited by novel p53 agonist inauhzin.
Alfhili MA; Alsalmi E; Aljedai A; Alsughayyir J; Abudawood M; Basudan AM
J Chemother; 2022 Jul; 34(4):247-257. PubMed ID: 34410893
[TBL] [Abstract][Full Text] [Related]
10. Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth.
Zhang Y; Zhang Q; Zeng SX; Zhang Y; Mayo LD; Lu H
Cancer Biol Ther; 2012 Aug; 13(10):915-24. PubMed ID: 22785205
[TBL] [Abstract][Full Text] [Related]
11. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
12. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
13. Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression.
Spurgers KB; Gold DL; Coombes KR; Bohnenstiehl NL; Mullins B; Meyn RE; Logothetis CJ; McDonnell TJ
J Biol Chem; 2006 Sep; 281(35):25134-42. PubMed ID: 16798743
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
15. Determination of Maximum Tolerated Dose and Toxicity of Inauhzin in Mice.
Zhang Q; Zeng SX; Lu H
Toxicol Rep; 2015; 2():546-554. PubMed ID: 26167454
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53.
Simões ML; Hockley SL; Schwerdtle T; Gamboa da Costa G; Schmeiser HH; Phillips DH; Arlt VM
Toxicol Appl Pharmacol; 2008 Oct; 232(1):86-98. PubMed ID: 18639569
[TBL] [Abstract][Full Text] [Related]
17. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
[TBL] [Abstract][Full Text] [Related]
18. Editor's Highlight: Hydroxyurea Exposure Activates the P53 Signaling Pathway in Murine Organogenesis-Stage Embryos.
El Husseini N; Schlisser AE; Hales BF
Toxicol Sci; 2016 Aug; 152(2):297-308. PubMed ID: 27208086
[TBL] [Abstract][Full Text] [Related]
19. p53-dependent change in replication timing of the human genome.
Watanabe Y; Shibata K; Sugimura H; Maekawa M
Biochem Biophys Res Commun; 2007 Dec; 364(2):289-93. PubMed ID: 17949684
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of HL-60 cells following knockdown of nucleostemin using DNA microarrays.
Sun X; Jia Y; Wei Y; Liu S; Yue B
Oncol Rep; 2014 Aug; 32(2):739-47. PubMed ID: 24912530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
